282 related articles for article (PubMed ID: 27110769)
1. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
[TBL] [Abstract][Full Text] [Related]
2. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
3. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
Chiang KC; Kuo SF; Chen CH; Ng S; Lin SF; Yeh CN; Chen LW; Takano M; Chen TC; Juang HH; Kittaka A; Lin JD; Pang JH
Cancer Lett; 2015 Dec; 369(1):76-85. PubMed ID: 26282787
[TBL] [Abstract][Full Text] [Related]
4. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
Yang SW; Tsai CY; Pan YC; Yeh CN; Pang JH; Takano M; Kittaka A; Juang HH; Chen TC; Chiang KC
Drug Des Devel Ther; 2016; 10():1995-2002. PubMed ID: 27382252
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.
Chiang KC; Yeh CN; Hsu JT; Jan YY; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Chen WT; Pang JH; Yeh TS; Juang HH
Cancer Lett; 2014 Nov; 354(2):235-44. PubMed ID: 25149065
[TBL] [Abstract][Full Text] [Related]
6. 1α,25(OH)
Chiang KC; Yeh CN; Pang JS; Hsu JT; Yeh TS; Chen LW; Kuo SF; Takano M; Chen TC; Kittaka A; Hsieh PJ; Juang HH
Anticancer Res; 2017 Nov; 37(11):6215-6221. PubMed ID: 29061804
[TBL] [Abstract][Full Text] [Related]
7. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
8. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
9. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
Chiang KC; Yeh CN; Chen HY; Lee JM; Juang HH; Chen MF; Takano M; Kittaka A; Chen TC
Steroids; 2011 Dec; 76(13):1513-9. PubMed ID: 21888924
[TBL] [Abstract][Full Text] [Related]
10. MART-10, a 1α,25(OH)
Chiang KC; Yeh CN; Yeh TS; Juang HH; Chen LW; Kuo SF; Chen MH; Chen TC; Takano M; Kittaka A; Pang JS
Anticancer Res; 2018 Jul; 38(7):3879-3887. PubMed ID: 29970508
[TBL] [Abstract][Full Text] [Related]
11. Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.
Ferrari-Amorotti G; Chiodoni C; Shen F; Cattelani S; Soliera AR; Manzotti G; Grisendi G; Dominici M; Rivasi F; Colombo MP; Fatatis A; Calabretta B
Neoplasia; 2014 Dec; 16(12):1047-58. PubMed ID: 25499218
[TBL] [Abstract][Full Text] [Related]
12. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-κB and Wnt/β-catenin signaling pathway.
Hseu YC; Lin YC; Rajendran P; Thigarajan V; Mathew DC; Lin KY; Way TD; Liao JW; Yang HL
Food Chem Toxicol; 2019 Feb; 124():219-230. PubMed ID: 30529123
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
[TBL] [Abstract][Full Text] [Related]
15. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
17. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition.
Wang H; Sang M; Geng C; Liu F; Gu L; Shan B
Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233
[TBL] [Abstract][Full Text] [Related]
18. 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition.
Hou YF; Gao SH; Wang P; Zhang HM; Liu LZ; Ye MX; Zhou GM; Zhang ZL; Li BY
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548154
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis.
Wilmanski T; Barnard A; Parikh MR; Kirshner J; Buhman K; Burgess J; Teegarden D
Nutr Cancer; 2016 Oct; 68(7):1202-9. PubMed ID: 27552186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]